Skip to content
TrialScanner

NCT03451292

Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites

Phase 3CompletedGRFSLead

Registry record

Lead sponsor
Grifols Therapeutics LLC
Conditions
Decompensated Cirrhosis and Ascites
Primary completion
May 21, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03451292 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03451292: Effects of Long-Term... | TrialScanner